National Cancer Survivors Month

Jacob’s Journey: A Childhood Cancer Survivor’s Story

Every battle has its heroes, and among the bravest are young children like Jacob Mozer, who faced stage 4 high-risk neuroblastoma when he was barely old enough to walk. Diagnosed at only 16 months old, Jacob’s early years were filled with constant medical appointments and intense treatments. Despite these challenges, today, Jacob is a shining example of the remarkable progress in pediatric oncology. He’s not merely surviving; he’s thriving as a pharmacy resident, driven to give back to the medical community that gave him a second chance at life.

During National Cancer Survivors Month this June, we honor and celebrate fighters like Jacob who have battled cancer and emerged stronger. This month also serves to amplify the conversation about pediatric cancer survivorship and push for vital research that continues to save lives. Solving Kids’ Cancer (SKC) plays an essential role in this effort, supporting children like Jacob by funding crucial clinical trials that enhance survival rates and improve the quality of life for those fighting fatal childhood cancers.

Jacob’s Journey: Early Diagnosis and Treatment

Jacob’s journey began with a sudden and alarming diagnosis of stage 4 high-risk neuroblastoma that plunged his family into uncertainty. “May 12, 1998, was the day my family’s life changed forever,” his father, Dr. Mark Mozer, recalled.1 The early symptoms were subtle and easily mistaken for common childhood issues — occasional vomiting and fussiness attributed to teething. Unfortunately, the truth was that it was a life-threatening tumor that demanded an immediate and aggressive treatment plan.

The first year was an ordeal filled with chemotherapy, stem-cell transplants, major surgeries, and groundbreaking therapies like monoclonal antibody treatment. “The oncologist told us that we were in for a long, difficult year … It was Jacob’s only chance,” said Dr. Mozer. Each phase of treatment brought its own set of challenges and risks. Still, Jacob’s parents fought tirelessly to secure the best care possible, turning their home into a command center for medical research and advocacy. This time tested their determination and strengthened their commitment to their son’s survival and health. 

A young boy sitting on a couch reading a book

The Importance of Family and Medical Support

The support of Jacob’s family was instrumental in navigating his early years of treatment. With a father who is a pediatrician and a mother who is a pharmacist, Jacob had the advantage of caregivers who could navigate the complex medical landscape more effectively than most. Dr. Mozer described their home environment as a hub of constant learning and advocacy: “Our dining room turned into a study hall, piled high with folders and papers.” They engaged directly with research and treatments, advocating for Jacob every step of the way, which was crucial in managing the intensive and often overwhelming treatment regimen prescribed to him.

Inspired by his medical journey and the caring example set by his parents, Jacob decided to become a pharmacist. As a pharmacy resident, he focuses on each patient’s needs, drawing on his experiences as a childhood cancer survivor to provide thoughtful and understanding care. “My time as a patient gives me a special understanding of what they go through. I know the worries about medications and how they affect daily life. So, I take my role seriously, always considering what’s best for the patient,” shared Jacob.

The Role and Impact of Clinical Trials

Clinical trials are crucial for developing new and more effective cancer treatments. Jacob’s involvement in a clinical trial at Sloan Kettering, where he received pioneering monoclonal antibody therapy, was a critical turning point in his cancer journey. 

“I was fortunate to be part of one of the early clinical trial groups. It was available back then, and I responded well to the treatments,” said Jacob. Access to this advanced medicine was a lifeline for Jacob and offered hope to many other children with similar diagnoses. 

Solving Kids’ Cancer (SKC) is instrumental in this field by actively finding, funding, and advocating for clinical trials focused on the most challenging pediatric cancers. Their efforts are crucial in pushing forward promising treatments such as:

  • Lorlatinib: A targeted therapy drug that addresses specific genetic abnormalities in cancer, offering a more personalized treatment approach.
  • International Consensus Protocol: This initiative aims to standardize treatment for ETMR (Embryonal Tumor with Multilayered Rosettes) cancer through international collaboration, enhancing the effectiveness and consistency of clinical trials across borders.
  • Minivan Trial: A study investigating the efficacy of combination therapies, which involves using multiple therapeutic approaches simultaneously to enhance treatment effectiveness.

Through these targeted trials, SKC not only boosts survival rates but also significantly impacts the quality of life for children battling cancer, demonstrating the power and necessity of specialized research in saving young lives.

Challenges of Pediatric Cancer Survivorship

Surviving cancer is just the beginning of a lifelong journey filled with unique challenges. For Jacob, this transition included regular visits to the survivorship clinic — sessions he didn’t look forward to. “As a kid, you dread those visits because you hate blood draws, you hate needles, and the hospital was full of those,” Jacob recalled. Though uncomfortable, these check-ups are vital for managing the long-term effects of cancer treatment, showing the need for continued medical support even after beating cancer.


Jacob’s battle with cancer left him with some long-term challenges, including hearing loss and dental issues that required multiple surgeries and treatments. However, Jacob learned how to cope with these difficulties over time. He adapted by using closed captioning for watching TV, reading lips to enhance understanding during conversations, and choosing not to use hearing aids despite the difficulties posed by his partial hearing loss.

“I found ways to live with it,” Jacob said, reflecting on his decision to forego hearing aids during his more self-conscious teenage years and his efforts to maintain normalcy. Many survivors like Jacob learn to become resilient as they navigate the complexities of life after cancer. 

Late Effects of Childhood Cancer

As with Jacob, the long-term effects of childhood cancer treatments can deeply impact survivors throughout their lives. Research shows that over 95% of those who survive childhood cancer will face significant health challenges by the time they reach 45 years old.2 These findings show the importance of ongoing research to cure cancer and reduce the lasting side effects of treatments.

Common late effects from childhood cancer treatment3 can include:

  • Growth and Development: Issues that can affect a survivor’s physical growth and overall development.
  • Organ Function: Potential long-term damage to organs that may affect their function.
  • Reproductive Health: Effects that might impact a survivor’s ability to have children and the health of those children.
  • Secondary Cancers: The risk of developing other forms of cancer later in life.
  • Psychosocial Trauma: Emotional and mental health challenges stemming from the cancer experience.

Understanding these challenges is crucial for providing survivors with the proper support and medical care as they age. Beating cancer is just one part of the journey. Ensuring a good quality of life post-treatment requires continued medical follow-up and support services to help manage these complex issues.

Encouragement and Advice for Survivors

Reflecting on his journey, Jacob offers a message of resilience and hope to other cancer childhood cancer survivors like him. “Learn to accept your situation and adjust your mindset accordingly,” he advised. “Don’t let your condition make you feel lesser.” 

Jacob also suggested practical ways to make everyday life easier, like using technology to help with physical challenges. For instance, he uses closed captioning on TV to help with his hearing difficulties and finds other minor adaptations to maintain a routine. These tips show how survivors can take control of their lives despite their conditions.

When asked why he chose his career in pharmacy, Jacob said, “I was always amazed by how medicine can make you feel better. It felt like magic to me.” This fascination led him to a career where he could help others, showing how personal challenges can lead to finding your passion.

Championing Change through Research Advocacy

Jacob stressed the importance of advocacy and giving back, which has been central to how his family copes and supports others. “We’ve been deeply involved in advocacy throughout my life,” Jacob said, sharing how their struggles inspire them to help others facing similar challenges. He highlighted a significant funding issue: Cancer is the number one cause of death by disease among children, but “only 4% of federal funding for cancer goes to childhood cancer.”4 Jacob believes funding needs to be more fairly allocated.

He also advocates for developing more drugs for rare childhood diseases, which often don’t attract enough financial interest from pharmaceutical companies. “It’s tough to get new treatments developed for rare diseases because there isn’t enough profit for the companies,” he explained. This shortfall shows the need for changes in the healthcare system that put patients’ needs before profit. Jacob and his family are committed to creating a healthcare system that treats its youngest patients with compassion and fairness. “If we can prevent this for anybody else, we want to be part of that effort,” he added.

Building a Brighter Future for Childhood Cancer Survivors

As we mark National Cancer Survivor Month, we reflect on the inspiring journey of survivors like Jacob, whose battle with stage 4 neuroblastoma showcases the critical advancements in pediatric oncology. From enduring intense treatments to becoming a proactive advocate and pharmacy resident, Jacob’s story embodies the transformative impact of dedicated medical research and patient support.

Your contribution can drive this crucial work forward. By donating to Solving Kids’ Cancer, you’re supporting pivotal clinical trials and research that save lives and improve the quality of life for children battling cancer. Invest in a future where young survivors like Jacob can thrive and lead the way for others — because every kid deserves to grow up.

A pink button that says give today on it
Source:
1 Blue Springs Teen Wins Volunteer Award – https://www.kmzu.com/news/local/blue-springs-teen-wins-volunteer-award/article_da74dc20-035e-5f8b-a90e-5bdf0c73904f.html
2 Clinical Care for People Who Survive Childhood Cancer: A Review – https://jamanetwork.com/journals/jama/article-abstract/2809804
3 Late Effects of Treatment for Childhood Cancer (PDQ®) – Health Professional Version – https://www.cancer.gov/types/childhood-cancers/late-effects-hp-pdq
By Kristi McKay December 2, 2024
Ways to Give Back During the Holidays
A man and a little girl are sitting in front of a wooden wall.
By duda November 20, 2024
Ahana’s Story of Strength with High-Risk Neuroblastoma Every day, over 1,000 children worldwide are diagnosed with cancer,1 and for many families, that diagnosis means facing an uncertain future. At just 20 months old, Ahana was diagnosed with a rare and aggressive cancer that had already spread through her small body. Her family’s search for life-saving childhood cancer treatments led them from South Africa to Spain and possibly toward a clinical trial in New York. Ahana’s journey shows the importance of supporting organizations like Solving Kids’ Cancer, which works to find, fund, and advocate for advanced treatments that give hope to families fighting against tough-to-treat rare pediatric cancers.
A poster for 2024 year in review for solving kids ' cancer
November 11, 2024
Advancing Childhood Cancer Research: SKC’s 2024 Milestones
A group of children are holding a sign that says
October 1, 2024
Lace Up for Kids: Your Impact on Childhood Cancer Research At Solving Kids’ Cancer, our mission has always been driven by hope — hope for better treatments, hope for breakthroughs, and most importantly, hope for every child fighting cancer. This year’s Lace Up for Kids campaign was nothing short of inspiring. Together, we’ve raised over $264,000 across the entire campaign, funding innovative childhood cancer research and providing more treatment options for children in need.  From coast to coast, nearly 4,000 participants have stepped up to lace up their gold shoelaces and make a difference. Whether it was through schools, sports teams, or community groups, the show of support has been overwhelming throughout the years. Over 7,823 donations have been made to accelerate new treatments, and the hashtag #CareWearShare has been used 13,864 times, spreading the message far and wide!
A girl is standing in front of a car in a parking lot.
September 2, 2024
Gold Laces for Childhood Cancer Awareness Month: Erin’s Story 
A group of children are standing in a circle with their shoes on the floor.
August 8, 2024
Smithtown Goes Gold for Childhood Cancer Awareness Month!
A poster for lace up for kids with a butterfly on it
August 6, 2024
Childhood Cancer Awareness Month: Lace Up for Kids 2024
A man standing on top of a mountain with the words osteosarcoma survivor to surgeon dr. kurt weiss ' story
August 1, 2024
Osteosarcoma Survivor to Surgeon: Dr. Kurt Weiss’ Story
By Kristi McKay July 4, 2024
A Quick Guide to Your Role as a Parent Advocate 
A close up of a person holding a test tube in a laboratory.
May 2, 2024
Trailblazing Treatments for Pediatric Brain Tumors Picture a fortress built to guard precious treasure but accidentally also keeps out the very allies it needs in a time of crisis. This is the challenge faced by medical researchers when dealing with the brain’s natural defense — the blood-brain barrier — especially in children with brain tumors. At Columbia University Medical Center, Dr. Luca Szalontay is leading the charge to breach this fortress with groundbreaking approaches. Recently, Dr. Timothy Cripe from Solving Kids’ Cancer’s podcast, This Week in Pediatric Oncology (TWIPO) , interviewed Dr. Szalontay to delve deeper into these innovative treatments. This Brain Tumor Awareness Month, we’re shining a light on these important advances in treating children’s cancer. Understanding the Challenge Treating pediatric brain tumors like diffuse midline glioma (DMG) is especially tough because of the brain’s own protective shield, known as the blood-brain barrier. This barrier keeps out most chemotherapy drugs as well as large molecules, like antibodies, making it hard to treat the tumors effectively. Dr. Szalontay describes the dilemma: “Our field hasn’t been able to advance as quickly as it has with leukemias or other solid tumors because the drugs don’t penetrate the brain efficiently.” She adds on the nature of this blood-brain barrier, “It’s evolutionary, very important to protect us from different toxins and harmful agents, but this is a shield which protects the tumor as well.” Even when drugs work well in lab tests, they struggle to get to the tumor in strong enough doses without harming the body. Dr. Szalontay also points out that DMG tumors are found in very sensitive areas of the brain, making traditional surgery or radiation risky because they could damage vital brain functions. This makes finding safe and effective treatments for these tumors even more challenging. So, what’s being done to tackle these obstacles and help kids fight these tumors?
More Posts